technology

TIL therapy

Tumor-infiltrating lymphocyte therapy — autologous polyclonal T-cells with broad neoantigen specificity, expanded from tumor tissue.

Where it's used

TIL therapy (tumor-infiltrating lymphocytes)
TIL therapy — autologous tumor-infiltrating T-cells with polyclonal specificity; the first approved drug Lifileucel (Amtagvi, Iovance, FDA 2024) is a breakthrough in metastatic melanoma.
therapeutics-platforms 4 min